Cargando…

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

BACKGROUND: Mutations in the receptor tyrosine kinase gene fibroblast growth factor receptor 2 (FGFR2) occur at a high frequency in endometrial cancer (EC) and have been linked to advanced and recurrent disease. However, little is known about how these mutations drive carcinogenesis. METHODS: Differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixit, Garima, Gonzalez‐Bosquet, Jesus, Skurski, Joseph, Devor, Eric J., Dickerson, Erin B., Nothnick, Warren B., Issuree, Priya D., Leslie, Kimberly K., Maretzky, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172618/ https://www.ncbi.nlm.nih.gov/pubmed/37165578 http://dx.doi.org/10.1002/ctm2.1223

Ejemplares similares

The Threshold Effect: Lipopolysaccharide-Induced Inflammatory Responses in Primary Macrophages Are Differentially Regulated in an iRhom2-Dependent Manner
por: Skurski, Joseph, et al.
Publicado: (2021)

The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders
por: Geesala, Ramasatyaveni, et al.
Publicado: (2020)

Functional Distinctions of Endometrial Cancer-Associated Mutations in the Fibroblast Growth Factor Receptor 2 Gene
por: Dixit, Garima, et al.
Publicado: (2023)

DNA demethylation fine‐tunes IL‐2 production during thymic regulatory T cell differentiation
por: Teghanemt, Athmane, et al.
Publicado: (2023)

Members of the Fibroblast Growth Factor Receptor Superfamily Are Proteolytically Cleaved by Two Differently Activated Metalloproteases
por: Dixit, Garima, et al.
Publicado: (2021)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
por: Bi, Jianling, et al.
Publicado: (2021)

The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes
por: Devor, Eric J, et al.
Publicado: (2018)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2022)

Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
por: Alabi, Rolake O., et al.
Publicado: (2021)

The Oncoplacental Gene Placenta-Specific Protein 1 Is Highly Expressed in Endometrial Tumors and Cell Lines
por: Devor, Eric J., et al.
Publicado: (2013)

RPLP1 Is Up-Regulated in Human Adenomyosis and Endometrial Adenocarcinoma Epithelial Cells and Is Essential for Cell Survival and Migration In Vitro
por: Peterson, Riley, et al.
Publicado: (2023)

miR-451 Deficiency Is Associated with Altered Endometrial Fibrinogen Alpha Chain Expression and Reduced Endometriotic Implant Establishment in an Experimental Mouse Model
por: Nothnick, Warren B., et al.
Publicado: (2014)

The emerging use of aromatase inhibitors for endometriosis treatment
por: Nothnick, Warren B
Publicado: (2011)

MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology
por: Nothnick, Warren B.
Publicado: (2022)

CD4 expression in effector T cells depends on DNA demethylation over a developmentally established stimulus-responsive element
por: Teghanemt, Athmane, et al.
Publicado: (2022)

EGFR isoforms and gene regulation in human endometrial cancer cells
por: Albitar, Lina, et al.
Publicado: (2010)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022)

Dissecting the miR-451a-Mif Pathway in Endometriosis Pathophysiology Using a Syngeneic Mouse Model: Temporal Expression of Lesion Mif Receptors, Cd74 and Cxcr4
por: Nothnick, Warren B., et al.
Publicado: (2022)

A Disintegrin and Metalloproteases (ADAMs): Activation, Regulation and Mechanisms of Catalysis
por: Maretzky, Thorsten
Publicado: (2021)

Human endometriotic lesion expression of the miR-144-3p/miR-451a cluster, its correlation with markers of cell survival and origin of lesion content
por: Nothnick, Warren B., et al.
Publicado: (2019)

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Terp, Mikkel G., et al.
Publicado: (2021)

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables
por: Salinas, Erin A., et al.
Publicado: (2019)

Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment
por: Nothnick, Warren, et al.
Publicado: (2016)

Bcl‐2 inhibitors enhance FGFR inhibitor‐induced mitochondrial‐dependent cell death in FGFR2‐mutant endometrial cancer
por: Packer, Leisl M., et al.
Publicado: (2019)

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?
por: Cappelletti, Maria Rosa, et al.
Publicado: (2015)

The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells
por: Devor, Eric J., et al.
Publicado: (2021)

The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022)

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()
por: Hovey, Adriann M., et al.
Publicado: (2015)

Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
por: Ware, Kathryn E., et al.
Publicado: (2010)

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma
por: Ni, Wei, et al.
Publicado: (2021)

Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA
por: Miller, Marina D., et al.
Publicado: (2019)

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2021)

Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying RUNX1 and NOTCH1 Gene Mutations
por: Wang, Xiaoxue, et al.
Publicado: (2019)

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2017)

The role of Notch signaling in endometrial mesenchymal stromal/stem-like cells maintenance
por: Zhang, Sisi, et al.
Publicado: (2022)

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer
por: Holdman, Xue B., et al.
Publicado: (2015)

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182
por: DEVOR, ERIC J., et al.
Publicado: (2016)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s5atb7nndihbhakk7kvabbubsl